Wedmont Private Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Buy
1,127
+12
+1% +$3.72K 0.01% 707
2026
Q2
$309K Buy
1,115
+78
+8% +$20.5K 0.01% 728
2026
Q1
$285K Buy
1,037
+53
+5% +$14.4K 0.01% 683
2025
Q4
$250K Buy
984
+72
+8% +$19.1K 0.01% 698
2025
Q3
$255K Sell
912
-17
-2% -$4.55K 0.01% 665
2025
Q2
$241K Buy
929
+9
+1% +$2.19K 0.01% 657
2025
Q1
$204K Buy
920
+44
+5% +$10.7K 0.01% 664
2024
Q4
$203K Buy
+876
New +$201K 0.01% 664
2024
Q1
– Sell
-965
Closed -$218K – 619
2023
Q4
$218K Buy
+965
New +$203K 0.02% 508

Other funds holding LH

Wedmont Private Capital's LH Position: Q3 2026 in Review

Wedmont Private Capital increased its Labcorp (LH) stake by 1.1% in Q3 2026, buying an estimated $3.72K and bringing the position to 1,127 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #707.

Wedmont Private Capital first reported a position in LH in Q4 2023 and has held it in 9 quarters since. 32 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Wedmont Private Capital held 1,127 shares of Labcorp worth $354K as of Q3 2026.
  • Wedmont Private Capital bought 12 Labcorp shares in Q3 2026, an estimated $3.72K.
  • Labcorp made up 0.01% of Wedmont Private Capital's portfolio in Q3 2026, its #707 holding.
  • Wedmont Private Capital first reported a position in Labcorp in Q4 2023 and has held it in 9 quarters since.
  • 32 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.